Henry Schein, Inc. (NASDAQ:HSIC) is Nuance Investments LLC's 3rd Largest Position

Nuance Investments LLC lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 22.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,278,081 shares of the company's stock after purchasing an additional 414,748 shares during the period. Henry Schein comprises approximately 5.6% of Nuance Investments LLC's holdings, making the stock its 3rd biggest holding. Nuance Investments LLC owned 1.80% of Henry Schein worth $166,072,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new stake in shares of Henry Schein during the second quarter valued at about $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein during the second quarter valued at approximately $37,000. Blue Trust Inc. raised its position in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after acquiring an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after buying an additional 346 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on HSIC shares. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Barrington Research restated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a report on Wednesday, August 7th. Finally, Robert W. Baird lowered their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and a consensus price target of $78.89.

Henry Schein Trading Down 1.5 %

HSIC stock traded down $1.11 during trading on Wednesday, reaching $73.73. The company had a trading volume of 3,170,671 shares, compared to its average volume of 1,384,593. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $9.19 billion, a P/E ratio of 30.34, a PEG ratio of 1.97 and a beta of 0.87. The business has a 50 day moving average of $70.68 and a 200 day moving average of $69.69. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the company earned $1.32 earnings per share. The firm's quarterly revenue was up .4% on a year-over-year basis. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company's stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.